Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Repare Therapeutics Inc. | EVP, CHIEF FINANCIAL OFFICER | Common Shares | 44.8K | $206K | $4.61 | Apr 1, 2024 | Direct |
Repare Therapeutics Inc. | EVP, CHIEF FINANCIAL OFFICER | Employee Stock Option (right to buy) | 85K | Mar 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RPTX | Repare Therapeutics Inc. | Mar 28, 2024 | 2 | -$7.45K | 4 | Apr 1, 2024 | EVP, CHIEF FINANCIAL OFFICER |
RPTX | Repare Therapeutics Inc. | Mar 25, 2024 | 3 | -$11.6K | 4 | Mar 27, 2024 | EVP, CHIEF FINANCIAL OFFICER |
RPTX | Repare Therapeutics Inc. | Mar 1, 2024 | 2 | $0 | 4 | Mar 5, 2024 | EVP, CHIEF FINANCIAL OFFICER |
RPTX | Repare Therapeutics Inc. | Jan 30, 2023 | 2 | $0 | 4 | Feb 1, 2023 | EVP, Chief Financial Officer |
RPTX | Repare Therapeutics Inc. | Jan 18, 2022 | 1 | $0 | 4 | Jan 20, 2022 | EVP, Chief Financial Officer |